Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1, NON-ALCOHOLIC FATTY LIVER DISEASE, AND ITS RELATIONSHIP WITH FRUCTOSE CONSUMPTION IN CHILDREN WITH OBESITY.

Flores-Ramírez AG, Ibarra-Reynoso LDR, López-Lemus HL, Olvera-Juárez M, Luevano-Contreras C, Garay-Sevilla ME.

Rev Invest Clin. 2019;71(5):339-348. doi: 10.24875/RIC.19002995.

2.

Soluble Receptor for Advanced Glycation End Products and Its Correlation with Vascular Damage in Adolescents with Obesity.

Rodríguez-Mortera R, Luevano-Contreras C, Solorio-Meza S, Gómez-Ojeda A, Caccavello R, Bains Y, Gugliucci A, Garay-Sevilla ME.

Horm Res Paediatr. 2019 Aug 14:1-8. doi: 10.1159/000501718. [Epub ahead of print]

PMID:
31412337
3.

Prediction of incident hypertension and arterial stiffness using the non-insulin-based metabolic score for insulin resistance (METS-IR) index.

Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, Martagón AJ, Mehta R, Arellano-Campos O, Gómez-Velasco DV, Almeda-Valdés P, Cruz-Bautista I, Melgarejo-Hernandez MA, Muñoz-Hernandez L, Guillén LE, Garduño-García JJ, Alvirde U, Ono-Yoshikawa Y, Choza-Romero R, Sauque-Reyna L, Garay-Sevilla ME, Malacara-Hernandez JM, Tusié-Luna MT, Gutierrez-Robledo LM, Gómez-Pérez FJ, Rojas R, Aguilar-Salinas CA.

J Clin Hypertens (Greenwich). 2019 Aug;21(8):1063-1070. doi: 10.1111/jch.13614. Epub 2019 Jul 18.

4.

Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, Blackwell TW, Boerwinkle E, Brody JA, Centeno-Cruz F, Chen L, Chen S, Contreras-Cubas C, Córdova E, Correa A, Cortes M, DeFronzo RA, Dolan L, Drews KL, Elliott A, Floyd JS, Gabriel S, Garay-Sevilla ME, García-Ortiz H, Gross M, Han S, Heard-Costa NL, Jackson AU, Jørgensen ME, Kang HM, Kelsey M, Kim BJ, Koistinen HA, Kuusisto J, Leader JB, Linneberg A, Liu CT, Liu J, Lyssenko V, Manning AK, Marcketta A, Malacara-Hernandez JM, Martínez-Hernández A, Matsuo K, Mayer-Davis E, Mendoza-Caamal E, Mohlke KL, Morrison AC, Ndungu A, Ng MCY, O'Dushlaine C, Payne AJ, Pihoker C; Broad Genomics Platform, Post WS, Preuss M, Psaty BM, Vasan RS, Rayner NW, Reiner AP, Revilla-Monsalve C, Robertson NR, Santoro N, Schurmann C, So WY, Soberón X, Stringham HM, Strom TM, Tam CHT, Thameem F, Tomlinson B, Torres JM, Tracy RP, van Dam RM, Vujkovic M, Wang S, Welch RP, Witte DR, Wong TY, Atzmon G, Barzilai N, Blangero J, Bonnycastle LL, Bowden DW, Chambers JC, Chan E, Cheng CY, Cho YS, Collins FS, de Vries PS, Duggirala R, Glaser B, Gonzalez C, Gonzalez ME, Groop L, Kooner JS, Kwak SH, Laakso M, Lehman DM, Nilsson P, Spector TD, Tai ES, Tuomi T, Tuomilehto J, Wilson JG, Aguilar-Salinas CA, Bottinger E, Burke B, Carey DJ, Chan JCN, Dupuis J, Frossard P, Heckbert SR, Hwang MY, Kim YJ, Kirchner HL, Lee JY, Lee J, Loos RJF, Ma RCW, Morris AD, O'Donnell CJ, Palmer CNA, Pankow J, Park KS, Rasheed A, Saleheen D, Sim X, Small KS, Teo YY, Haiman C, Hanis CL, Henderson BE, Orozco L, Tusié-Luna T, Dewey FE, Baras A, Gieger C, Meitinger T, Strauch K, Lange L, Grarup N, Hansen T, Pedersen O, Zeitler P, Dabelea D, Abecasis G, Bell GI, Cox NJ, Seielstad M, Sladek R, Meigs JB, Rich SS, Rotter JI; DiscovEHR Collaboration; CHARGE; LuCamp; ProDiGY; GoT2D; ESP; SIGMA-T2D; T2D-GENES; AMP-T2D-GENES, Altshuler D, Burtt NP, Scott LJ, Morris AP, Florez JC, McCarthy MI, Boehnke M.

Nature. 2019 Jun;570(7759):71-76. doi: 10.1038/s41586-019-1231-2. Epub 2019 May 22.

5.

Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort.

Arellano-Campos O, Gómez-Velasco DV, Bello-Chavolla OY, Cruz-Bautista I, Melgarejo-Hernandez MA, Muñoz-Hernandez L, Guillén LE, Garduño-Garcia JJ, Alvirde U, Ono-Yoshikawa Y, Choza-Romero R, Sauque-Reyna L, Garay-Sevilla ME, Malacara-Hernandez JM, Tusie-Luna MT, Gutierrez-Robledo LM, Gómez-Pérez FJ, Rojas R, Aguilar-Salinas CA.

BMC Endocr Disord. 2019 Apr 28;19(1):41. doi: 10.1186/s12902-019-0361-8.

6.

Association of Dietary Advanced Glycation End Products with Metabolic Syndrome in Young Mexican Adults.

Mendoza-Herrera K, Aradillas-García C, Mejía-Diaz MA, Alegría-Torres JA, Garay-Sevilla ME, Luevano-Contreras C.

Medicines (Basel). 2018 Dec 1;5(4). pii: E128. doi: 10.3390/medicines5040128.

7.

Advanced glycation end products and their receptors did not show any association with body mass parameters in metabolically healthy adolescents.

Garay-Sevilla ME, Torres-Graciano S, Villegas-Rodríguez ME, Rivera-Cisneros AE, Wrobel K, Uribarri J.

Acta Paediatr. 2018 Dec;107(12):2146-2151. doi: 10.1111/apa.14426. Epub 2018 Jun 19.

PMID:
29846968
8.

Changes in circulating levels of carboxymethyllysine, soluble receptor for advanced glycation end products (sRAGE), and inflammation markers in women during normal pregnancy.

Quintanilla-García CV, Uribarri J, Fajardo-Araujo ME, Barrientos-Romero JJ, Romero-Gutiérrez G, Reynaga-Ornelas MG, Garay-Sevilla ME.

J Matern Fetal Neonatal Med. 2018 Jun 25:1-6. doi: 10.1080/14767058.2018.1481948. [Epub ahead of print]

PMID:
29804482
9.

Higher D-lactate levels are associated with higher prevalence of small dense low-density lipoprotein in obese adolescents.

Rodríguez-Mortera R, Luevano-Contreras C, Solorio-Meza S, Caccavello R, Bains Y, Garay-Sevilla ME, Gugliucci A.

Clin Chem Lab Med. 2018 Jun 27;56(7):1100-1108. doi: 10.1515/cclm-2017-0733.

PMID:
29447114
10.

Comparative evaluation of three different ELISA assays and HPLC-ESI-ITMS/MS for the analysis of Nε-carboxymethyl lysine in food samples.

Gómez-Ojeda A, Jaramillo-Ortíz S, Wrobel K, Wrobel K, Barbosa-Sabanero G, Luevano-Contreras C, de la Maza MP, Uribarri J, Del Castillo MD, Garay-Sevilla ME.

Food Chem. 2018 Mar 15;243:11-18. doi: 10.1016/j.foodchem.2017.09.098. Epub 2017 Sep 20.

PMID:
29146316
11.

Obesity is associated with the Arg389Gly ADRB1 but not with the Trp64Arg ADRB3 polymorphism in children from San Luis PotosÍ and León, México.

Aradillas-Garc X Cd C, Cruz M, Pérez-Luque E, Garay-Sevilla ME, Malacara JM, R A, Peralta J, Burguete-García A, Alegría-Torres JA.

J Biomed Res. 2016 Oct 17;31(1):40-46. doi: 10.7555/JBR.30.20150169.

12.

Effect of Restriction of Foods with High Fructose Corn Syrup Content on Metabolic Indices and Fatty Liver in Obese Children.

Ibarra-Reynoso LDR, López-Lemus HL, Garay-Sevilla ME, Malacara JM.

Obes Facts. 2017;10(4):332-340. doi: 10.1159/000476069. Epub 2017 Aug 5.

13.

Dietary Advanced Glycation End Products and Cardiometabolic Risk.

Luévano-Contreras C, Gómez-Ojeda A, Macías-Cervantes MH, Garay-Sevilla ME.

Curr Diab Rep. 2017 Aug;17(8):63. doi: 10.1007/s11892-017-0891-2. Review.

PMID:
28695383
14.

Analysis of the interaction between transcription factor 7-like 2 genetic variants with nopal and wholegrain fibre intake: effects on anthropometric and metabolic characteristics in type 2 diabetes patients.

López-Ortiz MM, Garay-Sevilla ME, Tejero ME, Perez-Luque EL.

Br J Nutr. 2016 Sep;116(6):969-78. doi: 10.1017/S0007114516002798. Epub 2016 Aug 2.

PMID:
27480250
15.

The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients.

Villegas-Rodríguez ME, Uribarri J, Solorio-Meza SE, Fajardo-Araujo ME, Cai W, Torres-Graciano S, Rangel-Salazar R, Wrobel K, Garay-Sevilla ME.

PLoS One. 2016 Jul 19;11(7):e0159175. doi: 10.1371/journal.pone.0159175. eCollection 2016.

16.

Dietary restriction in obese children and its relation with eating behavior, fibroblast growth factor 21 and leptin: a prospective clinical intervention study.

Ibarra-Reynoso Ldel R, Pisarchyk L, Pérez-Luque EL, Garay-Sevilla ME, Malacara JM.

Nutr Metab (Lond). 2015 Sep 15;12:31. doi: 10.1186/s12986-015-0027-0. eCollection 2015.

17.

Determination of putrescine, cadaverine, spermidine and spermine in different chemical matrices by high performance liquid chromatography-electrospray ionization-ion trap tandem mass spectrometry (HPLC-ESI-ITMS/MS).

Ibarra AA, Wrobel K, Escobosa AR, Elguera JC, Garay-Sevilla ME, Wrobel K.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Oct 1;1002:176-84. doi: 10.1016/j.jchromb.2015.08.036. Epub 2015 Aug 28.

PMID:
26340761
18.

Dietary advanced glycation end products and their role in health and disease.

Uribarri J, del Castillo MD, de la Maza MP, Filip R, Gugliucci A, Luevano-Contreras C, Macías-Cervantes MH, Markowicz Bastos DH, Medrano A, Menini T, Portero-Otin M, Rojas A, Sampaio GR, Wrobel K, Wrobel K, Garay-Sevilla ME.

Adv Nutr. 2015 Jul 15;6(4):461-73. doi: 10.3945/an.115.008433. Print 2015 Jul. Review.

19.

Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men.

Macías-Cervantes MH, Rodríguez-Soto JM, Uribarri J, Díaz-Cisneros FJ, Cai W, Garay-Sevilla ME.

Nutrition. 2015 Mar;31(3):446-51. doi: 10.1016/j.nut.2014.10.004. Epub 2014 Nov 1.

20.

Molybdenum and copper in four varieties of common bean (Phaseolus vulgaris): new data of potential utility in designing healthy diet for diabetic patients.

Ojeda AG, Wrobel K, Escobosa AR, Elguera JC, Garay-Sevilla ME, Wrobel K.

Biol Trace Elem Res. 2015 Feb;163(1-2):244-54. doi: 10.1007/s12011-014-0191-5. Epub 2014 Nov 30.

PMID:
25433581
21.

Whole-body and hepatic insulin resistance in obese children.

Ibarra-Reynoso Ldel R, Pisarchyk L, Pérez-Luque EL, Garay-Sevilla ME, Malacara JM.

PLoS One. 2014 Nov 20;9(11):e113576. doi: 10.1371/journal.pone.0113576. eCollection 2014.

22.

Markers of the progression of complications in patients with type 2 diabetes: a one-year longitudinal study.

Preciado-Puga MC, Malacara JM, Fajardo-Araujo ME, Wröbel K, Wröbel K, Kornhauser-Araujo C, Garay-Sevilla ME.

Exp Clin Endocrinol Diabetes. 2014 Sep;122(8):484-90. doi: 10.1055/s-0034-1372594. Epub 2014 Sep 17.

PMID:
25230243
23.

High-performance liquid chromatography determination of glyoxal, methylglyoxal, and diacetyl in urine using 4-methoxy-o-phenylenediamine as derivatizing reagent.

Ojeda AG, Wrobel K, Escobosa AR, Garay-Sevilla ME, Wrobel K.

Anal Biochem. 2014 Mar 15;449:52-8. doi: 10.1016/j.ab.2013.12.014. Epub 2013 Dec 20.

PMID:
24361711
24.

Procedure to diagnose onychomycosis through changes in emissivity on infrared images.

Villaseñor-Mora C, Vega AG, Garay-Sevilla ME, Padilla-Medina JA, Arteaga-Murillo LI.

J Biomed Opt. 2013 Nov;18(11):116005. doi: 10.1117/1.JBO.18.11.116005.

25.

Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus.

Luévano-Contreras C, Garay-Sevilla ME, Wrobel K, Malacara JM, Wrobel K.

J Clin Biochem Nutr. 2013 Jan;52(1):22-6. doi: 10.3164/jcbn.12-40. Epub 2012 Dec 6.

26.

The relationship between dietary advanced glycation end products and indicators of diabetes severity in Mexicans and non-Hispanic whites: a pilot study.

Luevano-Contreras C, Garay-Sevilla ME, Preciado-Puga M, Chapman-Novakofski KM.

Int J Food Sci Nutr. 2013 Feb;64(1):16-20. doi: 10.3109/09637486.2012.704905. Epub 2012 Jul 10.

PMID:
22779780
27.

Distribution of the homeostasis model assessment of insulin resistance in Mexican children and adolescents.

Aradillas-García C, Rodríguez-Morán M, Garay-Sevilla ME, Malacara JM, Rascon-Pacheco RA, Guerrero-Romero F.

Eur J Endocrinol. 2012 Feb;166(2):301-6. doi: 10.1530/EJE-11-0844. Epub 2011 Nov 7.

PMID:
22065856
28.

Association of the TNF-α -308G/A polymorphism with family history of type 2 diabetes mellitus in a Mexican population.

Perez-Luque E, Malacara JM, Garay-Sevilla ME, Fajardo ME.

Clin Biochem. 2012 Jan;45(1-2):12-5. doi: 10.1016/j.clinbiochem.2011.09.018. Epub 2011 Oct 8.

PMID:
22015686
29.

Telomere length and type 2 diabetes in males, a premature aging syndrome.

Murillo-Ortiz B, Albarrán-Tamayo F, Arenas-Aranda D, Benítez-Bribiesca L, Malacara-Hernández JM, Martínez-Garza S, Hernández-González M, Solorio S, Garay-Sevilla ME, Mora-Villalpando C.

Aging Male. 2012 Mar;15(1):54-8. doi: 10.3109/13685538.2011.593658. Epub 2011 Aug 9.

PMID:
21824049
30.

Coping strategies and adherence to treatment in patients with type 2 diabetes mellitus.

Garay-Sevilla ME, Porras JS, Malacara JM.

Rev Invest Clin. 2011 Mar-Apr;63(2):155-61.

PMID:
21714436
31.

Trace elements status in diabetes mellitus type 2: possible role of the interaction between molybdenum and copper in the progress of typical complications.

Flores CR, Puga MP, Wrobel K, Garay Sevilla ME, Wrobel K.

Diabetes Res Clin Pract. 2011 Mar;91(3):333-41. doi: 10.1016/j.diabres.2010.12.014. Epub 2011 Jan 5.

PMID:
21211861
32.

Extensive demethylation of normally hypermethylated CpG islands occurs in human atherosclerotic arteries.

Castillo-Díaz SA, Garay-Sevilla ME, Hernández-González MA, Solís-Martínez MO, Zaina S.

Int J Mol Med. 2010 Nov;26(5):691-700.

PMID:
20878091
33.

TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects.

Garduño-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, Choza R, Sauque L, Garay-Sevilla ME, Malacara JM, Gomez-Perez FJ, Aguilar-Salinas CA.

Eur J Endocrinol. 2010 Aug;163(2):273-8. doi: 10.1530/EJE-10-0312. Epub 2010 Jun 1.

PMID:
20516204
34.

Effect of recreational physical activity on insulin levels in Mexican/Hispanic children.

Macias-Cervantes MH, Malacara JM, Garay-Sevilla ME, Díaz-Cisneros FJ.

Eur J Pediatr. 2009 Oct;168(10):1195-202. doi: 10.1007/s00431-008-0907-7. Epub 2009 Jan 14.

PMID:
19142662
35.

Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients.

Kornhauser C, Garcia-Ramirez JR, Wrobel K, Pérez-Luque EL, Garay-Sevilla ME, Wrobel K.

Prim Care Diabetes. 2008 Jun;2(2):81-5. doi: 10.1016/j.pcd.2008.02.003. Epub 2008 Apr 3.

PMID:
18684427
36.

Prediabetes in rural and urban children in 3 states in Mexico.

Aradillas-García C, Malacara JM, Garay-Sevilla ME, Guízar JM, Camacho N, De la Cruz-Mendoza E, Quemada L, Sierra JF.

J Cardiometab Syndr. 2007 Winter;2(1):35-9.

37.

Auditory impairment in patients with type 2 diabetes mellitus.

Díaz de León-Morales LV, Jáuregui-Renaud K, Garay-Sevilla ME, Hernández-Prado J, Malacara-Hernández JM.

Arch Med Res. 2005 Sep-Oct;36(5):507-10.

PMID:
16099330
38.

Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus.

Garay-Sevilla ME, Regalado JC, Malacara JM, Nava LE, Wróbel-Zasada K, Castro-Rivas A, Wróbel K.

J Endocrinol Invest. 2005 Mar;28(3):223-30.

PMID:
15952406
39.

Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial.

Rocha M, Nava LE, Vázquez de la Torre C, Sánchez-Márin F, Garay-Sevilla ME, Malacara JM.

J Periodontol. 2001 Feb;72(2):204-9.

PMID:
11288794
40.

Plasma epinephrine and norepinephrine response to stimuli in autonomic neuropathy of type 2 diabetes mellitus.

Granados G, Garay-Sevilla ME, Malacara JM, Wróbel-Zasada K, Rivera-Cisneros A.

Acta Diabetol. 2000;37(2):55-60.

PMID:
11194927
41.

Perceived psychological stress in diabetes mellitus type 2.

Garay-Sevilla ME, Malacara JM, González-Contreras E, Wróbel-Zasada K, Wróbel-Kaczmarczyk K, Gutiérrez-Roa A.

Rev Invest Clin. 2000 May-Jun;52(3):241-5.

PMID:
10953606
42.

Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus.

Garay-Sevilla ME, Nava LE, Malacara JM, Wróbel K, Wróbel K, Pérez U.

Diabetes Metab Res Rev. 2000 Mar-Apr;16(2):106-13.

PMID:
10751750
43.

Denial of disease in Type 2 diabetes mellitus: its influence on metabolic control and associated factors.

Garay-Sevilla ME, Malacara JM, Gutiérrez-Roa A, González E.

Diabet Med. 1999 Mar;16(3):238-44.

PMID:
10227570
44.

The belief in conventional medicine and adherence to treatment in non-insulin-dependent diabetes mellitus patients.

Garay-Sevilla ME, Malacara H JM, González-Parada F, Jordán-Ginés L.

J Diabetes Complications. 1998 Sep-Oct;12(5):239-45.

PMID:
9747639
46.

Adherence to treatment and social support in patients with non-insulin dependent diabetes mellitus.

Garay-Sevilla ME, Nava LE, Malacara JM, Huerta R, Díaz de León J, Mena A, Fajardo ME.

J Diabetes Complications. 1995 Apr-Jun;9(2):81-6.

PMID:
7599352

Supplemental Content

Loading ...
Support Center